These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18430393)

  • 21. [Assessment of bone quality. Bone quality and osteoporosis treatment].
    Mashiba T
    Clin Calcium; 2008 Mar; 18(3):300-7. PubMed ID: 18310816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Image assessment of the treatment effect on osteoporosis: bisphosphonates].
    Sone T
    Clin Calcium; 2011 Jul; 21(7):1041-6. PubMed ID: 21719985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the optimal duration of bisphosphonate therapy?
    Ott SM
    Cleve Clin J Med; 2011 Sep; 78(9):619-30. PubMed ID: 21885695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonate medications--the good, the bad, and the ugly.
    Bourgeois SL
    Tex Dent J; 2009 Jul; 126(7):596-604. PubMed ID: 19753815
    [No Abstract]   [Full Text] [Related]  

  • 25. [How anti-osteoporotic drugs work to improve bone metabolism].
    Takeuchi Y
    Nihon Rinsho; 2015 Oct; 73(10):1614-8. PubMed ID: 26536674
    [No Abstract]   [Full Text] [Related]  

  • 26. Bone markers and osteoporosis therapy.
    Bandeira F; Costa AG; Soares Filho MA; Pimentel L; Lima L; Bilezikian JP
    Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):504-13. PubMed ID: 25166041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bisphosphonate therapy for osteoporosis and bone strength].
    Kishimoto H
    Clin Calcium; 2006 Sep; 16(9):1513-19. PubMed ID: 16951477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of osteoporosis medications on bone quality.
    Benhamou CL
    Joint Bone Spine; 2007 Jan; 74(1):39-47. PubMed ID: 17196423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the bone.
    Cremers S; Farooki A
    Ann N Y Acad Sci; 2011 Feb; 1218():80-7. PubMed ID: 20946577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vitamin K2 treatment for osteoporosis: what is the evidence today?].
    Ishida Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():409-14. PubMed ID: 18161141
    [No Abstract]   [Full Text] [Related]  

  • 31. Alveolar bone and the bisphosphonates.
    Cheng A; Daly CG; Logan RM; Stein B; Goss AN
    Aust Dent J; 2009 Sep; 54 Suppl 1():S51-61. PubMed ID: 19737268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-osteoporotic drugs and vascular calcification: the bidirectional calcium traffic.
    Yavropoulou MP; Pikilidou M; Yovos JG
    J Vasc Res; 2014; 51(1):37-49. PubMed ID: 24280985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisphosphonate therapy and dental treatment.
    Phillips G
    J Indiana Dent Assoc; 2007-2008 Winter; 86(4):4-8. PubMed ID: 18363257
    [No Abstract]   [Full Text] [Related]  

  • 34. Bone turnover marker monitoring in osteoporosis treatment response.
    Tan RZ; Loh TP; Vasikaran S
    Eur J Endocrinol; 2020 Jun; 183(1):C5-C7. PubMed ID: 32504486
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of the combined extracts of Herba Epimedii and Fructus Ligustri Lucidi on bone mineral content and bone turnover in osteoporotic rats.
    Liu RH; Kang X; Xu LP; Nian HL; Yang XW; Shi HT; Wang XJ
    BMC Complement Altern Med; 2015 Apr; 15():112. PubMed ID: 25889254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTH analogues and osteoporotic fractures.
    Verhaar HJ; Lems WF
    Expert Opin Biol Ther; 2010 Sep; 10(9):1387-94. PubMed ID: 20629581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Frontiers in vitamin D; basic research and clinical application. Eldecalcitol: the effect on bones and calcium metabolism].
    Endo I; Matsumoto T
    Clin Calcium; 2011 Nov; 21(11):103-10. PubMed ID: 22040826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bone histomorphometry;A role of evaluation for bone quality and mechanical strength].
    Yamamoto N; Takahashi H; Shimakura T
    Clin Calcium; 2016 Jan; 26(1):9-15. PubMed ID: 26728526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT).
    Sugimoto T; Matsumoto T; Hosoi T; Miki T; Gorai I; Yoshikawa H; Tanaka Y; Tanaka S; Fukunaga M; Sone T; Nakano T; Ito M; Matsui S; Yoneda T; Takami H; Watanabe K; Osakabe T; Okubo N; Shiraki M; Nakamura T
    Osteoporos Int; 2015 Feb; 26(2):765-74. PubMed ID: 25403903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a place for bone turnover markers in the assessment of osteoporosis and its treatment?
    Devogelaer JP; Boutsen Y; Gruson D; Manicourt D
    Rheum Dis Clin North Am; 2011 Aug; 37(3):365-86, v-vi. PubMed ID: 22023897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.